Lead the commercial manufacturing and operations for Olema Oncology's innovative breast cancer treatments.
Posted by employer 1 day ago
First seen on Joblaze 6 hours ago
Last verified on the company career page 6 hours ago
What you'll build
Must have
Requirements
Not disclosed in this posting: work arrangement, visa sponsorship.
Benefits
Joblaze summary
The Senior Director of Commercial Manufacturing and Operations at Olema Oncology is responsible for developing and managing the commercial supply chain for their lead product, palazestrant. This role requires expertise in pharmaceutical manufacturing, supply planning, and regulatory compliance, along with a strong background in commercial launch strategies. Ideal candidates will have significant experience in small-molecule products and a proven track record in managing CDMO relationships. Olema's team is characterized by a collaborative culture and a commitment to transforming cancer treatment.
Joblaze insights
Quick facts
From the original posting
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. With our transformation into a fully integrated oncology company well underway, it’s an exciting time to be part of Team Olema.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in Q1 2027 which, if positive, could lead to our first potential approval and commercial launch in 2028. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant could transform the metastatic breast cancer treatment paradigm and provide access to a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently presented encouraging Phase 1 monotherapy data from this program across multiple solid tumor types, are advancing patient enrollment in the ongoing combination arms in MBC, and expect to initiate a Phase 1 study of OP-3136 in combination with Bayer’s darolutamide in metastatic castration-resistant prostate cancer by the end of this year.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and passionate colleagues dedicated to helping the patients we serve feel better, longer. Team Olema possesses a deep commitment to a shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, the drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. We are a small group of nimble self-starters who bring consistency in our quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
ABOUT THE ROLE
The Senior Director, Commercial Manufacturing & Operations is Olema’s senior leader accountable for building, scaling and governing the commercial manufacturing and supply platform for palazestrant. The role owns end-to-end commercial supply, spanning drug substance (DS), drug product (DP), packaging, labeling, serialization, inventory and distribution, and ensures uninterrupted, cost-effective supply to Olema’s 3PL and specialty pharmacy network. The Senior Director will set the commercial supply strategy, liaison with executive leadership, and own and executes the planning, inventory, vendor and logistics work behind it, then build the team as the business grows.
KEY RESPONSIBILITIES
Commercial Supply Strategy & Launch Readiness
Manufacturing & CDMO Governance (DS & DP)
Packaging, Labeling & Serialization
Supply Planning & Inventory
3PL & Distribution
Compliance & Organization Build
QUALIFICATIONS
ATTRIBUTES
The base pay range for this position is expected to be $260,000 - $285,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
Important Information >>>
Standard company text repeated across Olema Oncology's postings is omitted here.